Plantar fasciitis patients benefit from both autologous blood and corticosteroid injection .
Intralesional Autologous Blood Injection Compared to Corticosteroid Injection for Treatment of Chronic Plantar Fasciitis. A Prospective, Randomized, Controlled Trial
Foot Ankle Int. 2007 Sep;28(9):984-9064 adult patients with plantar fasciitis (for atleast 6 weeks) were randomized to either receive an autologous blood injection or a corticosteroid injection. The results indicate that both groups demonstrated a reduction in pain and tenderness over the 6 month period, though patients who received the corticosteroid injection showed a quicker and greater improvement than the autologous blood group. As a result, the use of an autologous blood injection in patients with plantar fasciitis is considered a beneficial and safe second-line alternative method of treatment.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
